Page 21 - Central Drug Authority Annual Report 2021
P. 21
4. STRATEGIC APPROACH TO THE NDMP 2019 –2024
7KH 1'03 SURYLGHV VWUDWHJLF GLUHFWLRQ WR WKH FRXQWU\ȠV 7R FRRUGLQDWH DQG GHOLYHU HIIHFWLYH JRYHUQPHQW SUHYHQ-
HIIRUWV WR GHDO ZLWK WKH XVH DQG DEXVH RI VXEVWDQFHV $FFRUG- WLRQ LQWHUYHQWLRQV LQ FRPEDWLQJ VXEVWDQFH DEXVH LOOLFLW
LQJ WR WKH 812'& D 1'03 LV GHˉQHG DV D VLQJOH GRFXPHQW GUXJ WUDGH DQG GUXJ WUDIˉFNLQJ WKURXJK WKH LPSOHPHQWD-
DGRSWHG E\ WKH JRYHUQPHQW RXWOLQLQJ DOO WKH QDWLRQDO WLRQ RI GHˉQHG RXWFRPHV DQG HIIHFWLYH PRQLWRULQJ DQG
FRQFHUQV LQ GUXJ FRQWURO ,W DXWKRULWDWLYHO\ VXPPDULVHV HYDOXDWLRQ RI LPSDFW WKDW ZLOO FRQWULEXWH WR WKH
QDWLRQDO SROLFLHV GHˉQHV SULRULWLHV DQG DOORFDWHV UHVSRQVL- FRPSOHWH HUDGLFDWLRQ RI XQHPSOR\PHQW SRYHUW\ DQG
ELOLWLHV IRU GUXJ FRQWURO HIIRUWV ,W DFWV ERWK DV D GLUHFWRU DQG LQHTXDOLW\ LQ 6RXWK $IULFD
D GLUHFWRU\ RI WKH FRXQWU\ȠV SROLFLHV DQG SURJUDPPHV LQ
DGGUHVVLQJ VXEVWDQFH XVH DQG DEXVH Principles of the NDMP
)XUWKHUPRUH WKH 1'03 DFWV DV D EOXHSULQW IRU HQVXULQJ WKDW Principle 1: Rights-based
H[LVWLQJ DQG QHZ UHVRXUFHV DUH KDUQHVVHG WR GHDO ZLWK 7KH 1'03 UHVSHFWV SURWHFWV DQG SURPRWHV
VXEVWDQFH DEXVH LVVXHV 7KH EOXHSULQW DOVR SURYLGHV D IUDPH- KXPDQ ULJKWV $OO REMHFWLYHV DUH EDVHG RQ KXPDQ ULJKWV
ZRUN IRU PRELOLVLQJ UHVRXUFHV RI QDWLRQDO DQG SURYLQFLDO SULQFLSOHV HQVKULQHG LQ WKH &RQVWLWXWLRQ RI WKH 5HSXEOLF RI
GHSDUWPHQWV WR VXSSRUW DFWLYLWLHV DOLJQHG ZLWK WKH FXUELQJ 6RXWK $IULFD
RI VXEVWDQFH XVH DQG DEXVH ZLWKLQ WKHLU SURJUDPPHV DQG
EXGJHWV
Principle 2: Evidence-based
7KH 3ODQ LV SUHPLVHG RQ HYLGHQFH DQG ZLOO EH DGDSWHG DV
7KH 1'03 VWUDWHJLF DSSURDFKHV DUH DV IROORZV QHZ HYLGHQFH EHFRPHV DYDLODEOH
,QWHJUDWHG DSSURDFK LQFOXGLQJ
D GHPDQG UHGXFWLRQ Principle 3: Multi-sectoral and multi-lateral
E VXSSO\ UHGXFWLRQ 7KH VXFFHVV RI WKH VWUDWHJ\ GHSHQGV RQ VHYHUDO JRYHUQPHQW
F DFFHVV WR GUXJV IRU PHGLFDO SXUSRVHV FRQWURO RI QHZ GHSDUWPHQWV DQG RWKHU VWDNHKROGHUV QDWLRQDOO\ DQG LQWHUQD-
SV\FKRDFWLYH VXEVWDQFHV WLRQDOO\ FRRSHUDWLQJ DW DOO OHYHOV WR DFKLHYH WKH JRDOV RI WKH
G JRYHUQDQFH DQG OHDGHUVKLS NDMP.
H VWUHQJWKHQLQJ GDWD FROOHFWLRQ DQG UHVHDUFK DQG
I VWLPXODWLQJ VXVWDLQDEOH HFRQRPLF JURZWK Principle 4: People-centred
:RUNLQJ LQ GHˉQHG RUJDQLVDWLRQDO FOXVWHUV WR LQWHJUDWH 7KH SODQ LV FRJQLVDQW RI WKH KDUPV UHODWHG WR 68' DQG
WKH LPSOHPHQWDWLRQ RI VWUDWHJLHV DGGUHVVHV GUXJ UHODWHG ELR SV\FKR VRFLR HFRQRPLF LVVXHV
'HOLYHULQJ PHDVXUDEOH RXWFRPHV DW ORFDO FRPPXQLW\ UHODWHG WR WKH LOOLFLW KRPH DQG FRPPHUFLDO FXOWLYDWLRQ PDQX-
GLVWULFW UHJLRQDO SURYLQFLDO DQG QDWLRQDO OHYHO IDFWXUH DQG SURGXFWLRQ RI DQG WUDIˉFNLQJ LQ GUXJV
'HOLYHULQJ PHDVXUDEOH RXWFRPHV LQ WKH VKRUW PHGLXP
DQG ORQJ WHUP DV UHTXLUHG E\ WKH 1'03 Principle 5: Inclusive and participatory
&RQVXOWLQJ H[WHQVLYHO\ RQ GHYHORSLQJ SODQV IRU WKH 3HRSOH ZKR XVH GUXJV DQG FRPPXQLWLHV PXVW EH FRQVXOWHG
future. LQ WKH GHYHORSPHQW DQG LPSOHPHQWDWLRQ RI WKH 1'03
8VLQJ DQDO\WLFDO DQG LQIRUPDWLRQ JDWKHULQJ PRGHOV WR 2019-2024.
JDWKHU IDFWXDO GDWD ZKLOH UHPRYLQJ HPRWLRQ IURP WKH
equation.
The Vision of the NDMP 2019-2024
$ 6RXWK $IULFD )UHH RI 6XEVWDQFH $EXVH
The Mission of the NDMP 2019 – 2024
7R HPEUDFH D EDODQFHG LQWHJUDWHG DQG HYLGHQFH EDVHG
DSSURDFK WR GRPHVWLF GUXJ XVH PLVXVH DQG DEXVH
7R LQYHVW LQ EXLOGLQJ VDIH FRPPXQLWLHV WKURXJK DSSURSUL-
DWH GUXJ SUHYHQWLRQ DQG LPSDFW PLQLPLVDWLRQ VWUDWHJLHV
7R FRQWURO WKH GHPDQG DQG VXSSO\ RI VXEVWDQFHV RI DEXVH
DQG PLVXVH
7R HIIHFWLYHO\ FRQWURO VXEVWDQFHV IRU WKHUDSHXWLF XVH DQG
WKH HPHUJHQFH RI 1HZ 3V\FKRDFWLYH 6XEVWDQFHV 136
Annual Report 2020/2021 Central Drug Authority 19
